CD8A and neoplasm: A separate study also demonstrated that adoptive transfer of NKG2D-based CAR T cells could recruit and activate endogenous antigen-specific CD4+ and CD8+ T cells at the tumor site in a CXCR3-dependent manner to achieve optimal eradication of ID8 ovarian cancer (116).